Replies to post #180642 on Elite Pharmaceuticals Inc (ELTP)

[Couch]

I know; like Elite would never have enough money for a phase 3 trial and that Nasrat would drop negative phase 3 results - whoops x 2 - sort of like saying upon Eli 200 launch the PPS isn't going to $2. That would be whoops x3. Next

[Dr PeteRose MLB]

There has been much information post here since the run to .97, so that statement is truly misinformation.
FACT:
Elite has completed every trial the FDA has requested.
FACT:
Elite Pharmaceuticals Announces Positive Top-Line Results From A Pivotal Phase 3 Study For Abuse-Deterrent Opioid ELI-200
Meets Primary and Secondary Endpoints
NORTHVALE, N.J., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced positive top-line results from the Phase 3 pivotal trial of its lead opioid abuse-deterrent candidate, ELI-200, for the treatment of moderate to severe pain.
The pivotal trial met its primary endpoint (p = 0.001), demonstrating statistical significance that the product provided pain relief following surgery in the treatment group using ELI-200 compared to the placebo group. Secondary endpoint results were consistent with primary findings and included safety measures. There were no serious adverse events or deaths related to ELI-200 reported during the conduct of the trial.
FACT:
The highly touted sub-penny AQUM does not exist anymore.
FACT:
Elite has risen from the lows of .06 to the present day price of .36 since Nasrat Hakim became CEO.